ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

AGLE Aeglea BioTherapeutics Inc

12.01
0.00 (0.00%)
最終更新日: 09:00:00
15分遅延
名称 銘柄コード 市場 種別
Aeglea BioTherapeutics Inc AGLE NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 12.01 09:00:00
始値 安値 高値 終値 前日終値
12.01
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3013:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/4/2605:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/4/2605:40EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/4/2605:21EDGAR2Form 8-K - Current report
2024/4/0205:06EDGAR2Form DEF 14A - Other definitive proxy statements
2024/3/2020:14EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/3/1905:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/3/1821:31EDGAR2Form 8-K - Current report
2024/3/1505:12EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/11/2906:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2821:33EDGAR2Form 8-K - Current report
2023/11/2806:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2806:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2806:32EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/2806:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/2806:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2722:30PRNUSAeglea BioTherapeutics Announces Name Change to Spyre..
2023/11/2310:45EDGAR2Form 8-K - Current report
2023/11/2307:00PRNUSAeglea BioTherapeutics Announces Grants of Inducement Awards
2023/11/1607:18EDGAR2Form S-1/A - General form for registration of securities..
2023/11/1607:14EDGAR2Form 8-K - Current report
2023/11/1505:13EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/11/1006:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:06EDGAR2Form 8-K - Current report
2023/11/1006:05PRNUSAeglea BioTherapeutics Reports Third Quarter 2023 Financial..
2023/11/0406:00PRNUSAeglea BioTherapeutics Announces Grants of Inducement Awards
2023/10/3109:00PRNUSAeglea BioTherapeutics to Participate in Upcoming November..
2023/10/2710:53EDGAR2Form DEF 14A - Other definitive proxy statements
2023/10/2422:00EDGAR2Form 8-K - Current report
2023/10/0710:40EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
2023/10/0606:13EDGAR2Form 8-K - Current report
2023/10/0307:02PRNUSAeglea BioTherapeutics Announces Grants of Inducement Awards
2023/9/2605:02EDGAR2Form 8-K - Current report
2023/9/1506:03PRNUSAeglea BioTherapeutics to Participate in Upcoming September..
2023/9/0906:05EDGAR2Form 8-K - Current report
2023/9/0721:40PRNUSAeglea BioTherapeutics Announces Reverse Stock Split
2023/9/0605:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0605:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/0605:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0605:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/0520:06EDGAR2Form 8-K - Current report
2023/9/0520:00PRNUSAeglea BioTherapeutics Expands Executive Leadership Team..
2023/8/1120:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1120:02EDGAR2Form 8-K - Current report
2023/8/1120:01EDGAR2Form 8-K - Current report
2023/8/1120:00PRNUSAeglea BioTherapeutics Reports Second Quarter 2023 Financial..
2023/8/0810:51EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/8/0805:25EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/7/2822:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/7/2720:01EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock